HLLY
Holley Inc.
HLLY has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
HLLY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
HLLY's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HLLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $1.05 | -55% |
| Current | 15x | $2.36 | — |
| Fair | 20x | $3.24 | +37% |
| Expensive | 28x | $4.43 | +88% |
Historical ranges are pointers, not guarantees.
HLLY's PE is in its fair range at 15x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HLLY Forward outlook
There aren't enough analyst estimates for HLLY to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HLLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.16 | +$0.38 |
| Q2 2026 | $0.09 | +$0.35 |
| Q1 2026 | $0.20 | +$0.41 |
| Q4 2025 | $0.16 | +$0.36 |
| Q3 2025 | -$0.22 | -283% |
| Q2 2025 | -$0.26 | -244% |
| Q1 2025 | -$0.21 | -240% |
| Q4 2024 | -$0.20 | -225% |
HLLY has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
HLLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.6M | +2.3% |
| Q2 2026 | $172M | +3.2% |
| Q1 2026 | $147.3M | -3.7% |
| Q4 2025 | $155.4M | +11% |
| Q3 2025 | $138.4M | +3.2% |
| Q2 2025 | $166.7M | -1.7% |
| Q1 2025 | $153M | -3.5% |
| Q4 2024 | $140.1M | -10% |
HLLY's revenue fell from its 2022 peak and has held roughly level since: $142M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +2.3 points |
| Q2 2026 | 1.6% | -15 points |
| Q1 2026 | 12% | -0.8 points |
| Q4 2025 | 13% | +33 points |
| Q3 2025 | 11% | +7.3 points |
| Q2 2025 | 17% | +0.1 points |
| Q1 2025 | 13% | +6.2 points |
| Q4 2024 | -21% | -33 points |
HLLY has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HLLY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HLLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.8M | +66% |
| Q2 2026 | $40.9M | +15% |
| Q1 2026 | -$6.3M | +$4.5M |
| Q4 2025 | $3.8M | +123% |
| Q3 2025 | $5.3M | +$8.8M |
| Q2 2025 | $35.7M | +47% |
| Q1 2025 | -$10.8M | -162% |
| Q4 2024 | $1.7M | -94% |
HLLY has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HLLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +593K shares |
| 1 year | +1.2% | +1.5M shares |
| 3 years | +1.4% | +1.6M shares |
| 5 years | +1170% | +111M shares |
HLLY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HLLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.4x | High |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 4.8x | High |
| Q4 2025 | 4.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 10.3x | High |
| Q1 2025 | 10.6x | High |
| Q4 2024 | 12.7x | High |
HLLY's net debt is about 5.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HLLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 21.7 | Neutral |
HLLY's weekly RSI is 43 (neutral) and its Stochastic is 22 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HLLY PE vs Consumer Cyclical Sector
| Metric | HLLY | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 18% below |
| PE % | 34 | 49 | 15 pts below |
HLLY is trading at 15x earnings, a 18% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HLLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.42 | 2.5% below |
| 20 week MA | $2.64 | 11% below |
| 50 week MA | $3.11 | 24% below |
| 100 week MA | $2.94 | 20% below |
| 200 week MA | $3.39 | 30% below |
HLLY is in a downtrend: it's below all five of its weekly moving averages, and 30% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HLLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.75 | $10.0 | +2.7% |
| 2021 | $10.0 | $12.6 | +26% |
| 2022 | $12.6 | $2.04 | -84% |
| 2023 | $2.04 | $4.87 | +139% |
| 2024 | $4.87 | $3.00 | -38% |
| 2025 | $3.00 | $4.17 | +39% |
| 2026 YTD | $4.17 | $2.36 | -43% |
HLLY has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.